A novel strategy to screen pregnant women for malaria with rapid
diagnostic tests and
treat the test - positive women with effective antimalarials does not lower the risk of adverse pregnancy outcomes compared with
treating all pregnant women with the malaria preventive sulfadoxine - pyrimethamine (SP) in sub-Saharan Africa, according to an open
label randomized trial published this week in PLOS Medicine by Feiko ter Kuile, of the Liverpool School of Tropical Medicine, and colleagues.